Clover Health Investments Corp [CLOV] stock prices are up 7.94% to $2.99 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CLOV shares have gain 19.12% over the last week, with a monthly amount glided 19.12%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Clover Health Investments Corp [NASDAQ: CLOV] stock has seen the most recent analyst activity on February 02, 2022, when Cowen upgraded its rating to a Market Perform and also revised its price target to $3 from $7. Previously, Canaccord Genuity started tracking the stock with Buy rating on February 02, 2022, and set its price target to $6. On January 19, 2022, SVB Leerink initiated with a Mkt Perform rating and assigned a price target of $3 on the stock. Credit Suisse downgraded its rating to a Underperform and reduced its price target to $3.50 on January 07, 2022. Cowen started tracking with a Underperform rating for this stock on September 10, 2021, and assigned it a price target of $7.
The stock price of Clover Health Investments Corp [CLOV] has been fluctuating between $0.61 and $3.82 over the past year. Currently, Wall Street analysts expect the stock to reach $2.15 within the next 12 months. Clover Health Investments Corp [NASDAQ: CLOV] shares were valued at $2.99 at the most recent close of the market. An investor can expect a potential drop of -28.09% based on the average CLOV price forecast.
Analyzing the CLOV fundamentals
The Clover Health Investments Corp [NASDAQ:CLOV] reported sales of 1.69B for trailing twelve months, representing a drop of -30.64%. Gross Profit Margin for this corporation currently stands at 0.18% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.08%, and Net Profit Margin reading is -0.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -0.4 and Total Capital is -0.35. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.85 points at the first support level, and at 2.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.07, and for the 2nd resistance point, it is at 3.14.
Ratios To Look Out For
It’s worth pointing out that Clover Health Investments Corp [NASDAQ:CLOV]’s Current Ratio is 1.69. Considering the valuation of this stock, the price to sales ratio is 0.88, the price to book ratio is 4.43.
Transactions by insiders
Recent insider trading involved Garipalli Vivek, Director, that happened on Aug 09 ’24 when 0.53 million shares were purchased. Director, Garipalli Vivek completed a deal on Jun 17 ’24 to buy 0.88 million shares. Meanwhile, Director Loengard Anna U bought 17085.0 shares on May 16 ’24.
